Nokia CorporationStock Exchange Release29 April 2025 at 15.45 EESTResolutions of Nokia Corporation’s Annual General MeetingEspoo, Finland – The Annual General Meeting (AGM) of Nokia Corporation took place today 29 April 2025 in Helsinki, Finland. The AGM approved all the proposals of the Board of Directors to the AGM. The AGM adopted the Company’s financial statements, discharged the members of the Board and the President and Chief Executive Officer from liability for the financial year 2024 and adopted the ...

登录新浪财经APP 搜索【信披】查看更多考评等级 股票简称：紫光股份股票代码：000938 公告编号：2025－026 紫光股份有限公司 关于修订公司章程及其附件的公告 本公司及董事会全体成员保证信息披露的内容真实、准确和完整，没有虚假记载、误导性陈述或重大遗 漏。 紫光股份有限公司（以下简称"公司"）于2025年4月28日召开第九届董事会第十二次会议、第九届监事 会第六次会议，审议通过了《关于修订<公司章程>及其附件的议案》，本议案尚需提交股东大会审 议，现将有关情况公告如下： 一、修订《公司章程》及其附件的原因及依据 根据《中华人民共和国公司法（2023年修订）》《上市公司章程指引》《深圳证券交易所股票上市规 则》《深圳证券交易所上市公司自律监管指引第1号——主板上市公司规范运作》等法律、法规的相关 规定，结合公司实际情况，公司对《紫光股份有限公司章程》及其附件《紫光股份有限公司股东会议事 规则》《紫光股份有限公司董事会议事规则》中相关条款作出相应修订。 二、《公司章程》的修订情况 2、本次修订后的《公司章程》及其附件全文详见同日披露于巨潮资讯网(http://www.cninfo.com.cn)的相 关 ...

First quarter financial results reflect strong energy demand from high-tech and data centers, which drove total quarter-over-quarter load growth of 4.6% and 16.4% industrial load growth Reaffirming 2025 adjusted earnings guidance of $3.13 to $3.33 per diluted share PORTLAND, Ore., April 25, 2025 /PRNewswire/ -- Portland General Electric Company (NYSE: POR) today reported net income based on generally accepted accounting principles (GAAP) of $100 million, or $0.91 per diluted share, for the first quarter o ...

Core Insights - Navitas Semiconductor has appointed Richard Hendrix as the new chair of the board, effective immediately, to enhance corporate governance and align board interests with stockholders [4][5] - The company has formed an executive steering committee to oversee strategic initiatives aimed at accelerating growth and profitability [8][11] - Daniel Kinzer has resigned from his executive roles but will continue to support the company in an advisory capacity [6][7] Corporate Governance Enhancements - Richard Hendrix, with over 30 years of capital markets experience, succeeds Gene Sheridan as chair while Sheridan remains CEO [4][5] - The board's commitment to strong corporate governance is emphasized, aiming to create value for stockholders [5] Strategic Initiatives - The executive steering committee will focus on expense management, product and technology roadmap acceleration, go-to-market strategies, and executive appointments [8][11] - The committee will work closely with CEO Gene Sheridan to ensure effective execution of these priorities [8] Market Position and Opportunities - Navitas is recognized as the only pure-play, next-generation power semiconductor company, specializing in GaN and SiC technologies [2][14] - The company aims to capitalize on multi-billion dollar market opportunities in sectors such as data centers, electric vehicles, and renewable energy [3][14]

Core Insights - Nature's Sunshine Products, Inc. published its 2024 Impact Report, highlighting its commitment to social responsibility and sustainability [1][2] - The report outlines significant progress towards the company's 2025 environmental, social, and governance (ESG) goals [2] ESG Goals and Achievements - The company aims to protect and preserve the environment as part of its mission, with a focus on community engagement and workforce development [2][3] - Nature's Sunshine received TRUE Zero Waste Gold Certification for its U.S. Distribution centers in May 2024 [5] - The company has helped over 1 million women and children worldwide obtain nutrition through partnerships with organizations like Vitamin Angels and Feed My Starving Children [5] - The Spanish Fork manufacturing plant was converted to 100% renewable energy in 2022 [5] - Scope 1 & 2 greenhouse gas emissions have been reduced since 2021, with a goal of a 50% reduction by the end of 2025 [5] - Waste reduction at the manufacturing facility has reached 32% since 2021, with a target of 35% by the end of 2025 [5] Company Overview - Nature's Sunshine Products is a leading natural health and wellness company, marketing and distributing products in over 40 countries [7] - The company manufactures most of its products in state-of-the-art facilities to ensure high quality, safety, and efficacy [7]

Core Insights - Nature's Sunshine Products, Inc. has published its 2024 Impact Report, highlighting its commitment to social responsibility and sustainability [1][2] - The report outlines significant progress towards the company's 2025 environmental, social, and governance (ESG) goals, emphasizing environmental stewardship and community engagement [2][3] ESG Goals and Achievements - The company aims for a 50% reduction in Scope 1 & 2 greenhouse gas emissions by the end of 2025, having already reduced emissions since 2021 [5] - Nature's Sunshine has achieved a 32% reduction in waste at its manufacturing facility since 2021, with a goal of reaching a 35% reduction by the end of 2025 [5] - The company received TRUE Zero Waste Gold Certification for its U.S. Distribution centers in May 2024 [5] Community Engagement - Nature's Sunshine has partnered with organizations like Vitamin Angels and Feed My Starving Children to help over 1 million women and children worldwide obtain essential nutrition [5] - The company emphasizes workforce development initiatives that empower employees to contribute to sustainability efforts [2][3] Brand Alignment - The 2024 Impact Report is titled "Be More Earth," aligning with the company's recent marketing and brand campaign [4]

The Sustainability Report provides data for 2022 through 2024 on the Company’s environmental, social, and governance initiativesMENLO PARK, Calif., April 23, 2025 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT), an eyecare technology company focused on developing and commercializing innovative, interventional technologies that elevate the standard of care, announced today that it has published its annual Sustainability Report, highlighting the Company’s sustainability activities, performance and res ...

Core Viewpoint - Climb Global Solutions, Inc. has elected Paul Giovacchini to its Board of Directors, expanding the Board to seven members, with six being independent under Nasdaq standards [1][2]. Group 1: Board Composition and Leadership - The election of Paul Giovacchini adds significant experience to the Board, with over 30 years in private equity, corporate governance, and board leadership [2]. - Giovacchini's previous roles include Lead Independent Director at TPI Composites, where he played a key role in transforming the company into a global public enterprise [2]. - The Chairman of the Board, John McCarthy, emphasized that Giovacchini's executive leadership and financial background will be crucial for Climb's operational foundation and growth initiatives [3]. Group 2: Company Overview - Climb Global Solutions, Inc. specializes in value-added global IT distribution and solutions, focusing on emerging and innovative technologies [4]. - The company operates across the US, Canada, and Europe through various business units, including Climb Channel Solutions, Grey Matter, and Climb Global Services [4]. - Climb provides IT distribution and solutions in sectors such as Security, Data Management, Connectivity, Storage & HCI, Virtualization & Cloud, and Software & ALM [4].

Core Insights - Lifecore Biomedical has appointed Thomas Salus as chief legal and administration officer and corporate secretary, bringing over 30 years of legal and management expertise, particularly in the life sciences industry [1][2][3] - Mr. Salus will oversee all legal activities and human resources, contributing to strategy development and corporate development focused on strategic alliances and partnerships [1][3] - The appointment is part of Lifecore's strategy to enhance corporate governance and SEC/Nasdaq reporting and compliance, aiming to streamline processes that impact performance [3] Company Overview - Lifecore Biomedical, Inc. is a fully integrated contract development and manufacturing organization (CDMO) specializing in the development, fill, and finish of sterile injectable pharmaceutical products [4] - The company has over 40 years of expertise in manufacturing premium, injectable-grade hyaluronic acid and partners with global and emerging biopharmaceutical and biotechnology companies across multiple therapeutic categories [4]

Hong Kong, March 31, 2025 (GLOBE NEWSWIRE) -- Wang and Lee Group, Inc. (NASDAQ: WLGS) today announced its strategic investment in Nasdaq-listed TROOPS, Inc. (NASDAQ: TROO). This collaboration aims to unlock synergies by integrating Wang and Lee's cutting-edge AI-driven advertising media, smart home devices, and blockchain-powered token rewards into TROOPS' expansive infrastructure. The proposed investment will enable Wang and Lee to deploy its AI-driven digital advertising platforms and IoT-enabled smart ho ...